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Marseille, 12) Laboratoire Alphabio, Marseille and 13) Service de Médecine Interne Maladies Infectieuses, Hôpital André Mignot, Le Chesnay, FranceAbstractClostridium difﬁcile causes antibiotic-associated diarrhoea and pseudomembranous colitis. The main virulence factors of C. difﬁcile are the
toxins A (TcdA) and B (TcdB). A third toxin, called binary toxin (CDT), can be detected in 17% to 23% of strains, but its role in human
disease has not been clearly deﬁned. We report six independent cases of patients with diarrhoea suspected of having C. difﬁcile infection
due to strains from toxinotype XI/PCR ribotype 033 or 033-like, an unusual toxinotype/PCR ribotype positive for CDT but negative for
TcdA and TcdB. Four patients were considered truly infected by clinicians and were speciﬁcally treated with oral metronidazole. One of
the cases was identiﬁed during a prevalence study of A−B−CDT+ strains. In this study, we screened a French collection of 220
nontoxigenic strains and found only one (0.5%) toxinotype XI/PCR ribotype 033 or 033-like strain. The description of such strains raises
the question of the role of binary toxin as a virulence factor and could have implications for laboratory diagnostics that currently rarely
include testing for binary toxin.
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E-mail: catherine.eckert@sat.aphp.frIntroductionClostridium difﬁcile is responsible for 15% to 25% of antibiotic-
associated diarrhoea and for more than 95% of pseudomem-
branous colitis. This Gram-positive spore-forming bacterium is
the major cause of hospital-acquired diarrhoea [1,2]. Sincew Microbe and New Infect 2015; 3: 12–17
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p://dx.doi.org/10.1016/j.nmni.2014.10.0032003, many countries have reported outbreaks of severe
C. difﬁcile infections (CDI). This trend is assumed to be due in
part to the emergence and rapid dissemination of an epidemic
clone of C. difﬁcile named NAP1/BI/027 [3]. Other changes have
been observed in the epidemiology of CDI: (a) community
cases of CDI have increased and have been described in people
previously considered to be at low risk [4,5], (b) another clone,
named 078, involved in severe CDI has been described [6], (c)
C. difﬁcile has been recognized as a pathogen or commensal in
numerous animals [7,8] and (4) detection of C. difﬁcile in food
products has been reported [4,9].
The main virulence factors of C. difﬁcile are two large clos-
tridial toxins, toxins A (TcdA) and B (TcdB), encoded by theEuropean Society of Clinical Microbiology and Infectious Diseases.
nses/by-nc-nd/3.0/)
NMNI Eckert et al. Binary toxin–positive C. difﬁcile strains 13genes tcdA and tcdB, respectively. These two genes are located
within a locus of pathogenicity (PaLoc) with three accessory
genes: tcdC, tcdR and tcdE. Sequencing of the PaLoc has indicated
a series of genetic polymorphisms. On the basis of PCR–re-
striction fragment length polymorphism of this locus, C. difﬁcile
strains are currently divided into 31 toxinotypes (or toxin
variant strains) that are characterized by insertions, deletions
and sequence mutations compared to the reference strain, VPI
10463 (toxinotype 0) [10,11]. Among the 31 toxinotypes, only
the toxinotype XI strains do not produce TcdA and TcdB (A−B−
strains) related to an absence of the tcdB gene and the presence
of a large deletion in the 50 region of the tcdA gene [10].
A third toxin, called binary toxin or CDT, was isolated for
the ﬁrst time by Popoff et al. [12] in a patient with severe
pseudomembranous colitis. This toxin is detected in 17% to
23% of C. difﬁcile strains in nonoutbreak situations [13–15].
This toxin is encoded by two genes, cdtA and cdtB, located on
the CDT locus (CdtLoc), which is separated from the PaLoc on
the C. difﬁcile chromosome [12,16]. Strains carrying the CdtLoc
belonged to speciﬁc toxinotypes, e.g. toxinotypes III, IV, V and
XI, or, more rarely, to strains for which the PaLoc is absent
[17]. The role of binary toxin in the pathophysiology of CDI
remains unclear [18].
Five nonepidemiologically related C. difﬁcile strains, charac-
terized by the absence of tcdB gene but the presence of the
binary toxin genes, and suspected to belong to the toxinotype
XI (A−B−CDT+), were sent to the National Reference Center
(NRC) for C. difﬁcile in Paris, France, between December 2011
and February 2013. The objectives of this study were to
conﬁrm the toxinotype of those strains, to describe the clinical
features of the ﬁve patients in whom these strains were isolated
and to estimate the prevalence of such strains that produce
binary toxin but not large clostridial toxins.Materials and methodsCharacterization of ﬁve strains with atypical toxin-
encoding gene content received by the NRC and
analysis of clinical data
Between December 2011 and February 2013, ﬁve strains with
atypical toxin-encoding gene content were sent to the NRC for
C. difﬁcile in Paris. Three of ﬁve strains were identiﬁed as
B−CDT+ using the molecular method Xpert® C. difﬁcile
(Cepheid, Sunnyvale, CA, USA) and were sent by the biologists
to the NRC for conﬁrmation of this particular result and to
exclude a genetic drift in tcdB. The two other strains were
characterized as A−B−CDT+ by the NRC performing routine
PCR targeting tcdA, tcdB, cdtA and cdtB genes on DNA extracted
from C. difﬁcile cultures.New Microbes and New Infections © 2014 The Authors. Published by Elsevier Ltd on beha
This is an open access artiDNA extraction from colonies of C. difﬁcile was performed
with the InstaGene Matrix kit® (Bio-Rad Laboratories, Hercu-
les, CA, USA). Ampliﬁcation by PCR of tcdA, tcdB, tcdC, cdtA and
cdtB genes coding for toxin A, toxin B, TcdC and the binary
toxin, respectively, was performed using primers described
elsewhere [13,19]. The toxinotypes were determined accord-
ing to the method described by Rupnik et al. [19]. Brieﬂy,
ampliﬁcation of A2 and A3 fragments of tcdA and B1, B2 and B3
fragments of tcdB was performed as described. Fragment A3
was digested using EcoRI to determine the toxinotype. PCR
ribotyping was performed as described by Bidet et al. [20].
In vitro toxin production was tested by inoculating two to ﬁve
colonies into brain–heart infusion broth (Oxoid, Hampshire,
England, UK) that was incubated 5 days under an anaerobic at-
mosphere. The supernatant was ﬁltered (0.22 μm pore size), and
the ﬁltrate was inoculated on MRC-5 cells. Toxin detection was
also tested by C. diff Quik Chek complete® (Alere, Orlando, FL,
USA) performed directly on colonies. Clinical data were reviewed
and analyzed for the ﬁve patients harbouring these strains.
Screening of a A−B− strain collection
To estimate the frequency of A−B−CDT+ strains, 220 consecu-
tive nontoxinogenic strains (A−B−) isolated in Paris (North of
France) (n = 84) and Montpellier (South of France) (n = 136)
between July 2011 and April 2013 were screened. All strains
were isolated from patients with diarrhoea who were suspected
of having CDI, who were admitted in Saint Antoine (Paris) or
Arnaud de Villeneuve (Montpellier) hospitals and strains were
characterized as nontoxinogenic strains by toxigenic culture
(TC). The in vitro determination of C. difﬁcile isolates ability to
produce toxins (TC) was performed either by inoculating su-
pernatant from a 5-day brain–heart infusion broth (Oxoid) on
MRC-5 cells (Paris) or by using ImmunoCard® Toxins A&B
(Meridian Bioscience, Cincinnati, OH, USA) directly on colonies
as recommended by the manufacturer (Montpellier).
Absence of the PaLoc was conﬁrmed as described elsewhere
by obtaining an ampliﬁcation of about 700 bp using primers lok1
and lok3 anchored outside the targeting PaLoc [21]. In case of a
negative result (i.e., absence of the PaLoc was not conﬁrmed),
ampliﬁcation by PCR of tcdA, tcdB, tcdC, cdtA and cdtB genes,
toxinotyping and PCR ribotyping were performed as described
above [13].ResultsCharacteristics of ﬁve A−B−CDT+ strains and
associated clinical data
Ampliﬁcation of B1, B2 and B3 fragments of tcdB was conﬁrmed
as negative for the ﬁve strains (data not shown). Only the 30lf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 3, 12–17.
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/)
FIG. 2. PCR ribotype of Clostridium difﬁcile A−B−CDT+ strains isolated
from patients compared with reference strains. Lanes: 1, DNA ladder
(bp); 2, PCR ribotype 027; 3, R11402 (reference strain; toxinotype XIb);
4, patient 2; 5, patient 4; 6, strain isolated in prevalence study; 7, 542
(reference strain; toxinotype XIa); 8, patient 1; 9, CD219 (reference
strain; PCR ribotype 033; toxinotype XIa); 10, patient 3; 11, patient 5.
14 New Microbes and New Infections, Volume 3 Number C, January 2015 NMNIregion (A2 and A3 fragments) of the tcdA gene was ampliﬁed for
all the strains. Binary toxin genes and a 39 bp deletion in tcdC
were identiﬁed in the ﬁve isolates. They were conﬁrmed to be
toxinotype XI strains after enzymatic restriction. Three isolates
were deﬁned as toxinotype XIa (EcoRI restriction pattern of A3
PCR fragment was of type 5d) and two isolates as XIb (EcoRI
restriction pattern of A3 PCR fragment was of type 8) (Fig. 1).
The ﬁve strains showed either a similar or slightly different PCR
ribotyping banding pattern as reference strains (R11402, 542
and CD219), suggesting that the ﬁve strains belonged to the
same lineage (Fig. 2). They were characterized as PCR ribotype
033 (or 033-like) isolates. The strains tested negative for their
in vitro toxin production either by the cytotoxicity assay on
MRC-5 cells or the C. diff Quik Chek complete® assay.
Clinical and biological data of the ﬁve patients were analyzed
(Table 1). The ﬁve patients were hospitalized in French hospi-
tals in different areas, and their infections were considered to
be epidemiologically unrelated. All ﬁve patients were symp-
tomatic (diarrheic stools) and had risk factors for CDI (antibi-
otics n = 5, age >65 years n = 3). Four of ﬁve patients
harbouring toxinotype XI strains were considered truly infec-
ted by their treating physician and were speciﬁcally treated with
oral metronidazole. The clinical presentation of one patient was
atypical because diarrhoea was probably the manifestation of
ileal CDI, as the patient had previously undergone a total
colectomy (Table 1, patient 1). One patient was not treated for
CDI, but symptomatic treatment was started and diarrhoea
resolved in the following days (patient 3).
Prevalence of A−B−CDT+ strains
Among the 220 studied strains, an ampliﬁcation was obtained
with primers lok1 and lok3, conﬁrming the absence of the
PaLoc, for 219 strains (99.5%). No ampliﬁcation could beFIG. 1. Restriction patterns obtained for A3 ampliﬁed fragment of tcdA
gene for Clostridium difﬁcile A−B−CDT+ strains isolated from patients
compared with reference strains. ND, unrestricted; E., EcoRI digestion.
Lanes: 1, DNA ladder (kb); 2, PCR ribotype 027; 3, 542 (reference
strain for toxinotype XIa); 4, CD219 (reference strain for toxinotype
XIa); 5, strain isolated from patient 1; 6, R11402 (reference strain for
toxinotype XIb); 7, strain isolated from patient 2.
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absent. These 219 strains were conﬁrmed as nontoxigenic
strains (A−B−CDT−). Absence of ampliﬁcation with primers
lok1 and lok3 was observed for one strain (0.5%). Further
ampliﬁcations for tcdA and tcdB showed the presence of the 30
region of tcdA only. This strain harboured a 39 bp deletion in
the tcdC gene. Binary toxin genes were present, and the strain
was characterized as toxinotype XIb. This strain belonged to
the same PCR ribotype (033/033-like) as the ﬁve toxinotype XI
strains previously identiﬁed in our laboratory (Fig. 2). Clinical
data for the patient hospitalized in Hôpital Saint Antoine, Paris,
and harbouring this strain were sparse; no speciﬁc treatment
was initiated despite clinical symptoms, probably because the
strain was reported as nontoxigenic by TC to the physician
(Table 1, patient 6).DiscussionWe report here the six ﬁrst strains of toxinotype XI isolated in
patients suspected of having CDI in France. Toxinotype XI
strains produce only binary toxin but not the common large
clostridial toxins TcdA and TcdB. Toxinotype XI strains are
atypical because they exhibit major rearrangement of the
PaLoc. Only portion of the 30 end region of PaLoc is present,
bearing part of the sequence of tcdA and tcdC, and the 50 region
covering tcdB, tcdR and tcdE is deleted [10]. Rupnik et al. [22]
described heterogeneity in the A3 region of tcdA that leads to
distinguish two subtypes, XIa and XIb. So far, toxinotype XI isEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 3, 12–17.
nses/by-nc-nd/3.0/)
TABLE 1. Clinical and biological data of the six patients harbouring A−B−CDT+ strains
Patient
no. Diagnostic
Toxino-
type
Date of
admission
(dd/mm/yy)
Sampling
date
(dd/mm/yy)
Age
(years) Gender
Ward/
hospital
Location
(city)
Main reason
for admission
White
blood
cell count
Origin
of
diarrhoea
Type of
diarrhoea
Salmonella,
Shigella,
Campylo-
bacter,
Yersinia
Previous
antibiotics
Speciﬁc
treatment
for CDI Outcome
1 B−CDT+
(Xpert C.
difﬁcile Assay,
Cepheid)
XIa 02/12/2011 29/12/2011 70 Male Vascular
surgery/
Hôpital
Henri
Mondor
Créteil
(North
of
France)
Surgical site
infection after
aortobifemoral
prosthetic
bypass
7.8 × 109/L HC-CDI Watery Absent Imipenem,
gentamicin
MTZ po,
500 mg 3
times a day
Diarrhoea
resolved/
no
recurrence
2 B−CDT+
(Xpert C.
difﬁcile Assay,
Cepheid)
XIb 05/10/2012 07/10/2012 81 Female Emergency
and internal
medicine,
infectious
disease/
Hôpital
André Mignot
Versailles
(North
of
France)
Pneumonia 2.9 × 109/L HC-CDI Watery
and
mucoid
Absent Piperacillin
and
tazobactam
MTZ po
500 mg 3
times a day
Diarrhoea
resolved/
no
recurrence
3 A−B−CDT+
(NRC, PCR
on colonies)
XIa 27/11/2012 03/12/2012 89 Male Long-term care/
Hôpital de
Bourg-en-
Bresse
Bourg-en-
Bresse
(Centre
of
France)
Vomiting and
repetitive falls,
pneumonia
6.4 × 109/L HC-CDI Bloody Absent Amoxicillin and
clavulanic
acid
No*
(symptomatic
treatment for
diarrhoea)
Diarrhoea
resolved
4 A−B−CDT+
(NRC, PCR
on colonies)
XIb 03/11/2012 04/12/2012 56 Male Nephrology/
Hôpital
Pellegrin
Bordeaux
(South
of
France)
Acute renal
failure and
pneumonia
13 × 109/L HC-CDI PMC ND Amoxicillin
and
clavulanic
acid
MTZ po 250 mg
3 times a day
Diarrhoea
resolved
5 B−CDT+
(Xpert C.
difﬁcile Assay,
Cepheid)
XIa 04/02/2013 05/02/2013 44 Male Hematology/
Institut Paoli
Calmette
Marseille
(South
of
France)
Febrile diarrhoea 25 × 109/L CO-HC-CDI Unknown ND Ticarcillin and
clavulanic acid
(+cancer
chemotherapy)
MTZ po 500 mg
3 times a day
Death
not related
to CDI
6 A−B−CDT+
(prevalence
study)
XIb 10/09/2012 18/09/2012 73 Male Hepatology-
gastroen-
terology/
Hôpital Saint
Antoine
Paris
(North
of
France)
Worsening of
general
conditions
with
hepatocellular
carcinoma
5.2 × 109/L HC-CDI Unknown Absent Unknown No Death not
related to
CDI
ND, not done; HC, health care associated; CDI, C. difﬁcile infection; CO, community onset; PMC, pseudomembranous colitis; MTZ, metronidazole; NRC, national reference centre.
*Clostridium difﬁcile has been isolated only by the NRC during EUropean, multicentre, prospective biannual point prevalence study of Clostridium difﬁcile Infection in hospitalized patients with Diarrhoea Euclid study. C. difﬁcile testing had not
been requested by the physician nor done by the laboratory. Because this study was noninterventional, the result was not immediately transmitted to the physician.
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16 New Microbes and New Infections, Volume 3 Number C, January 2015 NMNIthe only C. difﬁcile toxinotype to be positive for binary toxin but
negative for TcdA and TcdB production (A−B−CDT+) (http://
www.mf.uni-mb.si/tox/images/Table1_Toxinotypes-
characteristics.pdf).
Uncertainties still remain about the clinical signiﬁcance of
toxinotype XI in the pathogenesis of CDI because the role of
binary toxin as a virulence factor is still controversial [18]. This
toxin is produced by the highly virulent NAP1/BI/027 clone,
which has caused severe outbreaks in North America and
Europe, and by the emerging 078 clone, suggesting that it may
serve as an additional virulence factor and may act in synergy
with the large clostridial toxins [3]. A few clinical and epide-
miological studies that compared data from infections with
strains producing binary toxin in addition to TcdA and TcdB
and infections with strains producing only TcdA and TcdB
suggested that there could be a correlation between the pro-
duction of binary toxin and the severity of CDI [23–25]. A
case–control study conducted in 2005 compared the clinical
presentation of 26 patients infected with strains producing bi-
nary toxin in addition to toxins A and B to 42 controls infected
with strains producing only toxins A and B. Using univariate
analysis, diarrhoea due to a binary toxin–positive strain was
more often community acquired (p = 0.017) and associated
with abdominal pain (p = 0.07) than diarrhoea due to binary
toxin–negative strains. Diarrhoea was more often the cause of
hospitalization in cases than in controls (p = 0.003) [23]. A
more recent study reported that patients infected with
C. difﬁcile harbouring genes for toxins A and B and binary toxin
had higher case-fatality rates than patients infected with
C. difﬁcile harbouring genes for toxin A and B without binary
toxin [24]. Another study has shown that the presence of the
binary toxin gene in C. difﬁcile isolates was the only independent
predictive factor for recurrent CDI [25]. The effects of binary
toxin in animal models gave some conﬂicting results. In the
rabbit ileal loop model, inoculation of supernatants from cul-
ture of binary toxin–positive strains that produced neither
TcdA nor TcdB leads to enterotoxic response, suggesting that
binary toxin may act as a virulence factor. Nevertheless, in the
hamster model of ileocolitis, these strains produced no symp-
toms despite colonization [26]. Recent in vitro experiments have
shown that binary toxin induces redistribution of microtubules
and formation of long microtubule-based protrusions at the
surface of intestinal epithelial cells. The CDT-induced micro-
tubule protrusions form a dense mesh work at the cell surface,
which wrap and embed bacterial cells, thereby largely increasing
the adherence of C. difﬁcile [27]. Finally, the importance of bi-
nary toxin was demonstrated using isogenic toxin mutants
(A−B−CDT+) of NAP1/027/BI strains producing only binary
toxin inoculated to the hamsters [28]. Three of nine hamsters
inoculated with this A−B−CDT+ died.New Microbes and New Infections © 2014 The Authors. Published by Elsevier Ltd on behalf of
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licePCR ribotype 033 strains have been reported in animals. In
Australia, this PCR ribotype is the second most common strain
isolated in cattle and calves [29]. However, very few cases of
human CDI due to toxinotype XI have been described in the
literature. Among the ﬁve cases reported by Geric et al. [17],
three were from asymptomatic patients and one was from a
symptomatic patient; no clinical information was available for
the remaining case. In the present report, C. difﬁcile strains were
isolated from six symptomatic patients with several risk factors
for CDI, including advanced age and previous broad-spectrum
antibiotic treatment. Four of six patients were successfully
treated with metronidazole. These data support the conclusion
that diarrhoea in four patients was really due to C. difﬁcile.
Only a few studies have estimated the prevalence of tox-
inotype XI strains. In this study, we found a prevalence of 0.5%
(1/220). In a European study, 411 clinical C. difﬁcile isolates from
38 hospitals in 14 European countries were characterized by
toxinotyping. A total of 354 isolates (86.1%) were toxigenic.
Among the toxigenic isolates, 268 (75.7%) were from tox-
inotype 0; 86 strains (24.3%) belonged to nine variant tox-
inotypes, but none was of toxinotype XI [15]. A large collection
(5000 isolates) of C. difﬁcile isolates from the United States and
other sources over a 20-year period was examined for the
presence of binary toxin genes among strains that do not
produce TcdA and TcdB. Eight isolates have been reported as
A−B− but CDT+ [17]. Among these eight isolates, ﬁve had a
truncated PaLoc characteristic of toxinotype XI (including two
toxinotype XIa and three toxinotype XIb isolates). However,
most of the toxinotype XI strains isolated in that study were
recovered from asymptomatic patients. All these data indicate
that the prevalence of strains from toxinotype XI in humans
seems very low. However, we hypothesize that the prevalence
is likely underestimated. Indeed, the microbiological diagnosis of
CDI in France is mostly based on the detection of TcdA or
TcdB in stool samples, and clinical laboratories do not specif-
ically look for binary toxin. As a consequence, strains from
toxinotype XI would be likely reported as nontoxigenic isolates
when tested in a clinical laboratory. Since 2009, nucleic acid
ampliﬁcations assays have been increasingly used for the diag-
nosis of CDI. Most of the assays only target the tcdA or tcdB
genes of C. difﬁcile. Among these tests, the Xpert® C. difﬁcile
assay simultaneously detects three targets, including tcdB, binary
toxin genes and the deletion in position 117 within the tcdC
gene. This assay was initially developed in order to presump-
tively identify CDI due to the epidemic strain NAP1/BI/027
[3,30]. In recent years, this assay has been widely used in many
laboratories in France for the routine diagnosis of CDI. Three
cases of toxinotype XI that we report here were detected in
clinical laboratories using the Xpert C. difﬁcile assay and were
suspected only because of the presence of binary toxin gene. ItEuropean Society of Clinical Microbiology and Infectious Diseases, NMNI, 3, 12–17.
nses/by-nc-nd/3.0/)
NMNI Eckert et al. Binary toxin–positive C. difﬁcile strains 17is likely that the increasing use of this test will enable a better
recognition of toxinotype XI and therefore of its potential role
in clinical disease.
In conclusion, the present study suggests that C. difﬁcile
strains producing only binary toxin seem to be pathogenic
despite the lack of TcdA and TcdB. A result of C. difﬁcile testing
that would be only positive by PCR for binary toxin should be
taken into account and may reveal a toxinotype XI strain.
However, the prevalence of toxinotype XI seems low in France.Conﬂict of interestNone declared.References[1] Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G,
Kainer MA, et al. Multistate point-prevalence survey of health care–
associated infections. N Engl J Med 2014;370:1198–208.
[2] Rupnik M, Wilcox MH, Gerding DN. Clostridium difﬁcile infection: new
developments in epidemiology and pathogenesis. Nat Rev 2009;7:
526–36.
[3] McDonald LC, Killgore GE, Thompson A, Owens RC, Kazakova SV,
Sambol SP, et al. An epidemic, toxin gene–variant strain of Clostridium
difﬁcile. N Engl J Med 2005;353:2433–41.
[4] Hensgens MPM, Keessen EC, Squire MM, Riley TV, Koene MGJ, de
Boer E, et al. Clostridium difﬁcile infection in the community: a zoonotic
disease? Clin Microbiol Infect 2012;18:635–45.
[5] Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN.
A case–control study of community-associated Clostridium difﬁcile
infection. J Antimicrob Chemother 2008;62:388–96.
[6] Goorhuis A, Bakker D, Corver J, Debast SB, Harmanus C,
Notermans DW, et al. Emergence of Clostridium difﬁcile infection due
to a new hypervirulent strain, polymerase chain reaction ribotype 078.
Clin Infect Dis 2008;47:1162–70.
[7] Avbersek J, Janezic S, Pate M, Rupnik M, Zidaric V, Logar K, et al.
Diversity of Clostridium difﬁcile in pigs and other animals in Slovenia.
Anaerobe 2009;15:252–5.
[8] Riley TV, Adams JE, O’Neill GL, Bowman RA. Gastrointestinal carriage
of Clostridium difﬁcile in cats and dogs attending veterinary clinics.
Epidemiol Infect 1991;107:659–65.
[9] Eckert C, Burghoffer B, Barbut F. Contamination of ready-to-eat raw
vegetables with Clostridium difﬁcile in France. J Med Microbiol
2013;62(pt 9):1435–8.
[10] Geric Stare B, Rupnik M. Clostridium difﬁcile toxinotype XI (A−B−)
exhibits unique arrangement of PaLoc and its upstream region.
Anaerobe 2010;16:393–5.
[11] Rupnik M. Heterogeneity of large clostridial toxins: importance of
Clostridium difﬁcile toxinotypes. FEMS Microbiol Rev 2008;32:541–55.
[12] Popoff MR, Rubin EJ, Gill DM, Boquet P. Actin-speciﬁc ADP-
ribosyltransferase produced by a Clostridium difﬁcile strain. Infect
Immun 1988;56:2299–306.New Microbes and New Infections © 2014 The Authors. Published by Elsevier Ltd on beha
This is an open access arti[13] Eckert C, Coignard B, Hebert M, Tarnaud C, Tessier C, Lemire A,
et al. Clinical and microbiological features of Clostridium difﬁcile in-
fections in France: the ICD-RAISIN 2009 national survey. Med Mal
Infect 2013;43:67–74.
[14] Bauer MP, Notermans DW, van Benthem BHB, Brazier JS,
Wilcox MH, Rupnik M, et al. Clostridium difﬁcile infection in Europe: a
hospital-based survey. Lancet 2011;377(9759):63–73.
[15] Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I.
Prospective study of Clostridium difﬁcile infections in Europe with
phenotypic and genotypic characterisation of the isolates. Clin
Microbiol Infect 2007;13:1048–57.
[16] Perelle S, Gibert M, Bourlioux P, Corthier G, Popoff MR. Production
of a complete binary toxin (actin-speciﬁc ADP-ribosyltransferase) by
Clostridium difﬁcile CD196. Infect Immun 1997;65:1402–7.
[17] Geric B, Johnson S, Gerding DN, Grabnar M, Rupnik M. Frequency of
binary toxin genes among Clostridium difﬁcile strains that do not pro-
duce large clostridial toxins. J Clin Microbiol 2003;41:5227–32.
[18] Gerding DN, Johnson S, Rupnik M, Aktories K. Clostridium difﬁcile bi-
nary toxin CDT: mechanism, epidemiology, and potential clinical
importance. Gut Microbes 2013;5(1).
[19] Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. A novel
toxinotyping scheme and correlation of toxinotypes with serogroups of
Clostridium difﬁcile isolates. J Clin Microbiol 1998;36:2240–7.
[20] Bidet P, Barbut F, Lalande V, Burghoffer B, Petit JC. Development of a
new PCR-ribotyping method for Clostridium difﬁcile based on ribosomal
RNA gene sequencing. FEMS Microbiol Lett 1999;175:261–6.
[21] Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-
Streiber C. Deﬁnition of the single integration site of the pathogenicity
locus in Clostridium difﬁcile. Gene 1996;181:29–38.
[22] Rupnik M, Brazier JS, Duerden BI, Grabnar M, Stubbs SL. Comparison
of toxinotyping and PCR ribotyping of Clostridium difﬁcile strains and
description of novel toxinotypes. Microbiology 2001;147(pt 2):
439–47.
[23] Barbut F, Decre D, Lalande V, Burghoffer B, Noussair L, Gigandon A,
et al. Clinical features of Clostridium difﬁcile–associated diarrhoea due
to binary toxin (actin-speciﬁc ADP-ribosyltransferase)-producing
strains. J Med Microbiol 2005;54(pt 2):181–5.
[24] Bacci S, Mølbak K, Kjeldsen MK, Olsen KEP. Binary toxin and death
after Clostridium difﬁcile infection. Emerg Infect Dis 2011;17:976–82.
[25] Stewart DB, Berg A, Hegarty J. Predicting recurrence of C. difﬁcile
colitis using bacterial virulence factors: binary toxin is the key.
J Gastrointest Surg 2013;17:118–24.
[26] Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP,
Lyerly DM, et al. Binary toxin-producing, large clostridial toxin-
negative Clostridium difﬁcile strains are enterotoxic but do not cause
disease in hamsters. J Infect Dis 2006;193:1143–50.
[27] Schwan C, Stecher B, Tzivelekidis T, van Ham M, Rohde M, Hardt W-
D, et al. Clostridium difﬁcile toxin CDT induces formation of
microtubule-based protrusions and increases adherence of bacteria.
PLoS Pathog 2009;5:e1000626.
[28] Kuehne SA, Collery MM, Kelly ML, Cartman ST, Cockayne A,
Minton NP. Importance of toxin A, toxin B, and CDT in virulence of an
epidemic Clostridium difﬁcile strain. J Infect Dis 2014;209:83–6.
[29] Knight D, Thean S, Putsathit P, Fenwick S, Riley TV. Cross-sectional
study reveals high prevalence of Clostridium difﬁcile non-PCR ribotype
078 strains in Australian veal calves at slaughter. Appl Environ
Microbiol 2013;79:2630–5.
[30] Goldenberg SD, Dieringer T, French GL. Detection of toxigenic
Clostridium difﬁcile in diarrheal stools by rapid real-time polymerase
chain reaction. Diagn Microbiol Infect Dis 2010;67:304–7.lf of European Society of Clinical Microbiology and Infectious Diseases, NMNI, 3, 12–17.
cle under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/)
